Načítá se...
Novel inhibitors of human immunodeficiency virus type 2 infectivity
Human immunodeficiency virus type 2 (HIV-2) infects about two million people worldwide. HIV-2 has fewer treatment options than HIV-1, yet may evolve drug resistance more quickly. We have analysed several novel drugs for anti-HIV-2 activity. It was observed that 5-azacytidine, clofarabine, gemcitabin...
Uloženo v:
| Vydáno v: | J Gen Virol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Society for General Microbiology
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4233633/ https://ncbi.nlm.nih.gov/pubmed/25103850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1099/vir.0.069864-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|